Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Anna Kotzeva, Deepali Mittal, Supriya Desai, Davneet Judge & Kunal Samanta. (2023) Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries. Journal of Medical Economics 26:1, pages 70-83.
Read now
Read now
Charmi Patel, Dominic Pilon, Laura Morrison, Christopher Holiday, Marie-Hélène Lafeuille, Patrick Lefebvre & Carmela Benson. (2023) Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stay. Current Medical Research and Opinion 39:8, pages 1157-1166.
Read now
Read now
Maryia Zhdanava, H Lynn Starr, Todor I Totev, Patrick Lefebvre, Aditi Shah, Kristy Sheng & Dominic Pilon. (2022) Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey. Neuropsychiatric Disease and Treatment 18, pages 2003-2019.
Read now
Read now
Antoine C El Khoury, Charmi Patel, Panagiotis Mavros, Ahong Huang, Li Wang & Richa Bashyal. (2021) Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate Among Veterans with Schizophrenia. Neuropsychiatric Disease and Treatment 17, pages 3159-3170.
Read now
Read now
Renato de Filippis, Pasquale De Fazio, Raffaele Gaetano, Luca Steardo, Clemente Cedro, Antonio Bruno, Rocco Antonio Zoccali & Maria Rosaria Anna Muscatello. (2021) Current and emerging long-acting antipsychotics for the treatment of schizophrenia. Expert Opinion on Drug Safety 20:7, pages 771-790.
Read now
Read now
Xinyu Fang, Yewei Wang, Yan Chen, Juanjuan Ren & Chen Zhang. (2019) Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics. Neuropsychiatric Disease and Treatment 15, pages 2161-2170.
Read now
Read now
Antoine El Khoury, Charmi Patel, Ahong Huang, Li Wang & Richa Bashyal. (2019) Transitioning from oral risperidone or paliperidone to once-monthly paliperidone palmitate: a real-world analysis among Veterans Health Administration patients with schizophrenia who have had at least one prior hospitalization. Current Medical Research and Opinion 35:12, pages 2159-2168.
Read now
Read now
Articles from other publishers (9)
Gabriel G. Edwards, Ayako Miyashita-Ochoa, Enrico G. Castillo, David Goodman-Meza, Ippolytos Kalofonos, Raphael J. Landovitz, Arleen A. Leibowitz, Craig Pulsipher, Ed El Sayed, Steven Shoptaw, Chelsea L. Shover, Michelle Tabajonda, Yvonne S. Yang & Nina T. Harawa. (2022) Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine. AIDS and Behavior 27:1, pages 10-24.
Crossref
Crossref
Yael Barer, Rinat Ribalov, Ayelet Yaari, Ron Maor, Qais Arow, John Logan, Gabriel Chodick, David Arkadir & Renana Eitan. (2022) The Clinical and Economic Burden of Tardive Dyskinesia in Israel. Journal of Clinical Psychopharmacology 42:5, pages 454-460.
Crossref
Crossref
Amber Martin, Leona Bessonova, Rachel Hughes, Michael J. Doane, Amy K. O’Sullivan, Kassandra Snook, Allie Cichewicz, Peter J. Weiden & Philip D. Harvey. (2022) Systematic Review of Real-World Treatment Patterns of Oral Antipsychotics and Associated Economic Burden in Patients with Schizophrenia in the United States. Advances in Therapy 39:9, pages 3933-3956.
Crossref
Crossref
Charmi Patel, Ahong Huang, Li Wang, Yoshita Paliwal & Kruti Joshi. (2022) Patient Journey of Veterans with Schizophrenia: An Analysis of Treatment Patterns, Healthcare Resource Utilization and Costs. Advances in Therapy 39:3, pages 1199-1214.
Crossref
Crossref
Héctor Cabello-Rangel, Armando Arredondo, Lina Díaz-Castro, Hortensia Reyes-Morales & María Elena Medina-Mora. (2022) An estimate of the economic burden of schizophrenia in Mexico: a retrospective study in the psychiatric hospital setting. Journal of Global Health Neurology and Psychiatry.
Crossref
Crossref
Vanteemar S. Sreeraj, Venkataram Shivakumar, Naren P. Rao & Ganesan Venkatasubramanian. 2022. Long-Acting Drug Delivery Systems. Long-Acting Drug Delivery Systems
203
222
.
Samuel D. Clark, Jared X. Van Snellenberg, Jacqueline M. Lawson & Anissa Abi-Dargham. (2020) Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: a meta-analysis of controlled trials. Neuropsychopharmacology 45:11, pages 1860-1869.
Crossref
Crossref
Dong-Eun Seo, Seonji Kim & Byung-Joo Park. (2020) Signals of Adverse Drug Reactions of Paliperidone Compared to Other Atypical Antipsychotics Using the Korean Adverse Event Reporting System Database. Clinical Drug Investigation 40:9, pages 873-881.
Crossref
Crossref
Charmi Patel, Antoine El Khoury, Ahong Huang, Li Wang & Richa Bashyal. (2020) Healthcare Resource Utilization and Costs Among Patients With Schizophrenia Switching From Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: A Veterans Health Administration Claims Analysis. Current Therapeutic Research 92, pages 100587.
Crossref
Crossref